Genomic, Proteomic Tools May Yield 'Simplistic' or 'Misleading' Conclusions, Cancer Review Finds | GenomeWeb
NEW YORK (GenomeWeb News) — Data generated by genomic and proteomic technologies are overly complex, causing some cancer researchers to arrive at “simplistic” or “misleading” conclusions, according to a review article in the January issue of Nature Reviews Cancer.
 
The study, led by researchers at Georgetown University Medical Center, concluded that scientists “don’t appreciate how complex the data is that is being generated.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.